Reaction Details Report a problem with these data
Target
Prostacyclin receptor
Ligand
BDBM50233520
Substrate
n/a
Meas. Tech.
ChEMBL_1650990 (CHEMBL4000124)
EC50
>10000±n/a nM
Citation
Sandham, DA; Barker, L; Brown, L; Brown, Z; Budd, D; Charlton, SJ; Chatterjee, D; Cox, B; Dubois, G; Duggan, N; Hall, E; Hatto, J; Maas, J; Manini, J; Profit, R; Riddy, D; Ritchie, C; Sohal, B; Shaw, D; Stringer, R; Sykes, DA; Thomas, M; Turner, KL; Watson, SJ; West, R; Willard, E; Williams, G; Willis, J Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP ACS Med Chem Lett 8:582-586 (2017) [PubMed] Article
More Info.:
Target
Name:
Prostacyclin receptor
Synonyms:
PGI receptor | PI2R_HUMAN | PRIPR | PTGIR | Prostacyclin (IP) Receptor | Prostacyclin receptor | Prostaglandin I | Prostaglandin I2 | Prostaglandin I2 receptor | Prostanoid IP receptor
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
40968.22
Organism:
Homo sapiens (Human)
Description:
The membranes prepared from human platelet were used in binding assay.
Residue:
386
Sequence:
MADSCRNLTYVRGSVGPATSTLMFVAGVVGNGLALGILSARRPARPSAFAVLVTGLAATDLLGTSFLSPAVFVAYARNSSLLGLARGGPALCDAFAFAMTFFGLASMLILFAMAVERCLALSHPYLYAQLDGPRCARLALPAIYAFCVLFCALPLLGLGQHQQYCPGSWCFLRMRWAQPGGAAFSLAYAGLVALLVAAIFLCNGSVTLSLCRMYRQQKRHQGSLGPRPRTGEDEVDHLILLALMTVVMAVCSLPLTIRCFTQAVAPDSSSEMGDLLAFRFYAFNPILDPWVFILFRKAVFQRLKLWVCCLCLGPAHGDSQTPLSQLASGRRDPRAPSAPVGKEGSCVPLSAWGEGQVEPLPPTQQSSGSAVGTSSKAEASVACSLC